Cite

Trimethylamine oxide and serum amyloid A in diagnosis of chronic cerebral hypoperfusion

MLA

ZHANG Xin, et al. “Trimethylamine Oxide and Serum Amyloid A in Diagnosis of Chronic Cerebral Hypoperfusion.” Zhongguo Linchuang Yanjiu, vol. 36, no. 8, Aug. 2023, pp. 1170–74. EBSCOhost, https://doi.org/10.13429/j.cnki.cjcr.2023.08.012.



APA

ZHANG Xin, ZHANG Jing, CHENG Xudong, ZHANG Qi, ZHOU Sen, JIA Lijun, WANG Lirong, & YU Nengwei. (2023). Trimethylamine oxide and serum amyloid A in diagnosis of chronic cerebral hypoperfusion. Zhongguo Linchuang Yanjiu, 36(8), 1170–1174. https://doi.org/10.13429/j.cnki.cjcr.2023.08.012



Chicago

ZHANG Xin, ZHANG Jing, CHENG Xudong, ZHANG Qi, ZHOU Sen, JIA Lijun, WANG Lirong, and YU Nengwei. 2023. “Trimethylamine Oxide and Serum Amyloid A in Diagnosis of Chronic Cerebral Hypoperfusion.” Zhongguo Linchuang Yanjiu 36 (8): 1170–74. doi:10.13429/j.cnki.cjcr.2023.08.012.